patents

'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered'
'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered'
Fierce Pharma
Teva Pharmaceutical
GSK
Coreg
patents
Flag link:
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Xconomy
patents
Alexion
Amgen
biosimilars
USPTO
Flag link:
Why Mallinckrodt Stock Is Plunging Today
Why Mallinckrodt Stock Is Plunging Today
Motley Fool
Mallinckrodt
opioids
patents
Flag link:
Alexion shares slide on Amgen patent challenge to top-seller
Alexion shares slide on Amgen patent challenge to top-seller
Biopharma Dive
Amgen
Alexion
inter partes review
patents
Soliris
Flag link:
Three strategies for managing loss of exclusivity successfully
Three strategies for managing loss of exclusivity successfully
Pharmaforum
market exclusivity
patents
Humalog
Viagra
Eli Lilly
Pfizer
Flag link:
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Praluent
Repatha
Flag link:
Here's Why Mallinckrodt Fell Over 17% Today
Here's Why Mallinckrodt Fell Over 17% Today
Motley Fool
Mallinckrodt
Inomax
patents
Noxivent
Praxair
Flag link:
Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack
Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack
Fierce Pharma
Pfizer
patents
Lyrica
generics
Flag link:
Biopharma's biggest sellers – the oldies that just keep giving
Biopharma's biggest sellers – the oldies that just keep giving
Evaluate Pharma
Amgen
Enbrel
patents
biologics
Advair
Zantac
Liptor
Plavix
Flag link:
Sanofi defends top oncology drug with Jevtana patent win
Sanofi defends top oncology drug with Jevtana patent win
Fierce Pharma
Sanofi
patents
generics
Jevtana
oncology
Flag link:
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Novartis
Sandoz
biosimilars
Amgen
Enbrel
patents
Erelzi
Flag link:
What Enbrel needs to do after its patent win
What Enbrel needs to do after its patent win
EP Vantage
Amgen
Enbrel
patents
generics
Flag link:
Enbrel ruling lifts Amgen shares
Enbrel ruling lifts Amgen shares
BioCentury
Amgen
Enbrel
patents
Sandoz
generics
Flag link:
Lyrica Patent Expiration Ushers In 9 Generic Competitors
Lyrica Patent Expiration Ushers In 9 Generic Competitors
Xtalks
Pfizer
Lyrica
patents
generics
Alembic Pharmaceuticals
Alkem Laboratories
Amneal
Dr Reddy's
InvaGen
MGN Laboratories
Rising Pharmaceuticals
Sciegen Pharmaceuticals
Teva Pharmaceutical
Flag link:
Lyrica generics roll: Pfizer blockbuster finally hits patent cliff
Lyrica generics roll: Pfizer blockbuster finally hits patent cliff
Fierce Pharma
Pfizer
Lyrica
FDA
patents
Flag link:
Here's Why Pacific Biosciences Is Tumbling Today
Here's Why Pacific Biosciences Is Tumbling Today
Motley Fool
Pacific Biosciences
Europe
patents
DNA sequencing
Flag link:
German court blocks sale of Sanofi, Regeneron cholesterol drug
German court blocks sale of Sanofi, Regeneron cholesterol drug
Biopharma Dive
patents
Amgen
Sanofi
Regeneron
Germany
Praluent
Repatha
Flag link:
Alexion’s Soliris follow-up Ultomiris snares EU approval
Alexion’s Soliris follow-up Ultomiris snares EU approval
Pharmaforum
Alexion
Europe
Ultomiris
Soliris
patents
PNH
Flag link:
Pfizer's About to Enter a Sales Slump
Pfizer's About to Enter a Sales Slump
Motley Fool
Pfizer
Lyrica
patents
Flag link:
U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached?
U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached?
Fierce Pharma
Gilead Sciences
Truvada
HIV
patents
Flag link:

Pages